Related Experiment Video
Updated: Dec 10, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Target/therapies for chronic recurrent erythema nodosum leprosum
Pugazhenthan Thangaraju1, Shoban Babu Varthya2, Sajitha Venkatesan3
1Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Abstract:
A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nephrotic Syndrome II : Assessment and Medical Management
Clinical Applications of Epidermal Stem Cells
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

